为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

1,2-苯基异恶唑

规格或纯度: >96.0%(GC)
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
B151955-200mg
200mg 现货 Stock Image
B151955-1g
1g 现货 Stock Image
B151955-5g
5g 现货 Stock Image
B151955-25g
25g 现货 Stock Image
查看相关系列
五元杂环化合物 恶唑类

基本描述

别名 1,2-苯异唑
英文别名 J-016689|Q791818|Z220335556|DTXSID20181567|EN300-25961|G9L6B3W684|1,2-benzoisoxazole|CHEBI:51554|Benzo[d]isoxazole|A818951|benzisoxazole|SCHEMBL2213595|THUJAPLICIN, BETA|Indoxazene|FT-0627231|1,2-benzoxazole|CS-0155959|1,2-Benzisoxazole|Elsix|D879RKM5NQ|M
规格或纯度 >96.0%(GC)
英文名称 1,2-Benzisoxazole
储存温度 2-8°C储存,避光,充氩
运输条件 冰袋运输
产品介绍

1,2-Benzisoxazole derivative zonisamide is a novel antiepileptic drμg and is effective for the treatment of partial seizures. 1,2-Benzisoxazole is a potential substrates of rabbit liver aldehyde oxidase.

1,2-Benzisoxazole derivative zonisamide is a novel antiepileptic drug and is effective for the treatment of partial seizures. 1,2-Benzisoxazole is a potential substrates of rabbit liver aldehyde oxidase.

名称和标识符

IUPAC Name 1,2-benzoxazole
INCHI InChI=1S/C7H5NO/c1-2-4-7-6(3-1)5-8-9-7/h1-5H
InChi Key KTZQTRPPVKQPFO-UHFFFAOYSA-N
Canonical SMILES C1=CC=C2C(=C1)C=NO2
Isomeric SMILES C1=CC=C2C(=C1)C=NO2
WGK Germany 3
PubChem CID 71073
分子量 119.12
Beilstein号 2154

化学和物理性质

溶解性 Soluble in water. 4.1 mg/mL in water at 25°C
密度 1.169
敏感性 对光、热、空气敏感
折光率 1.562
闪点(℉) 186.8 °F
闪点(℃) 86°C
沸点 90-92°C

安全和危险性(GHS)

象形图
ghs07

Harmful

信号词 Warning
危险声明 H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
预防措施声明 P261,P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P271,P304+P340,P403+P233,P362+P364,P264+P265,P337+P317,P332+P317,P319
WGK Germany 3
个人防护装备 Eyeshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Koon HW, Shih D, Karagiannides I, Zhao D, Fazelbhoy Z, Hing T, Xu H, Lu B, Gerard N, Pothoulakis C.  (2010)  Substance P modulates colitis-associated fibrosis..  Am J Pathol,  177  (5):  (2300-9).  [PMID:20889569]
2. D H Peters,E M Sorkin.  (1993-05-01)  Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy..  Drugs,  45  ((5)):  (760-787).  [PMID:7686468]
3. Fu-Jun Liu,Aaron Barchowsky,Patricia L Opresko.  (2009-06-03)  The Werner syndrome protein functions in repair of Cr(VI)-induced replication-associated DNA damage..  Toxicological sciences : an official journal of the Society of Toxicology,  110  ((2)):  (307-318).  [PMID:19487340]
4. Nigel Greene,Lilia Fisk,Russell T Naven,Reine R Note,Mukesh L Patel,Dennis J Pelletier.  (2010-06-18)  Developing structure-activity relationships for the prediction of hepatotoxicity..  Chemical research in toxicology,  23  ((7)):  (1215-1222).  [PMID:20553011]
5. Sean Ekins,Antony J Williams,Jinghai J Xu.  (2010-09-17)  A predictive ligand-based Bayesian model for human drug-induced liver injury..  Drug metabolism and disposition: the biological fate of chemicals,  38  ((12)):  (2302-2308).  [PMID:20843939]
6. Hon Wai Koon,David Q Shih,Tressia C Hing,Jeremy Chen,Samantha Ho,Dezheng Zhao,Stephan R Targan,Charalabos Pothoulakis.  (2011-09-29)  Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells..  The American journal of pathology,  179  ((5)):  (2315-2326).  [PMID:21945803]
7. Dallas R Donohoe,Darcy Holley,Leonard B Collins,Stephanie A Montgomery,Alan C Whitmore,Andrew Hillhouse,Kaitlin P Curry,Sarah W Renner,Alicia Greenwalt,Elizabeth P Ryan,Virginia Godfrey,Mark T Heise,Deborah S Threadgill,Anna Han,James A Swenberg,David W Threadgill,Scott J Bultman.  (2014-10-01)  A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner..  Cancer discovery,  ((12)):  (1387-1397).  [PMID:25266735]
8. Min Bao,Chengtuo Niu,Xin Xu,Feiyun Zheng,Chunfeng Liu,Jinjing Wang,Qi Li.  (2019-06-25)  Identification, soluble expression, and characterization of a novel endo-inulinase from Lipomyces starkeyi NRRL Y-11557..  International journal of biological macromolecules,  137  ():  (537-544).  [PMID:31233793]
9. W Gristwood,K Wilson.  (1988-08-01)  Kinetics of some benzothiazoles, benzoxazoles, and quinolines as substrates and inhibitors of rabbit liver aldehyde oxidase..  Xenobiotica; the fate of foreign compounds in biological systems,  18  ((8)):  (949-954).  [PMID:3188574]
10. Hon-Wai Koon,Dezheng Zhao,Hua Xu,Collin Bowe,Alan Moss,Mary P Moyer,Charalabos Pothoulakis.  (2008-07-05)  Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis..  The American journal of pathology,  173  ((2)):  (400-410).  [PMID:18599605]
11. Avneet Kaur,Dharam P Pathak,Vidushi Sharma,Sharad Wakode.  (2018-05-10)  Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents..  Archiv der Pharmazie,  351  ((6)):  (e1800008-e1800008).  [PMID:29741797]